AVINGER
Avinger, Inc., a medical device company, engages in developing catheter-based technologies for treating vascular diseases. It offers Wildcat, a catheter that helps physicians in treating peripheral artery disease. The company also produces the Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The company was founded in 2007 by John B. Simpson and is based in Redwood City, California.
AVINGER
Industry:
Health Care Manufacturing Medical Medical Device
Founded:
2007-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.avinger.com
Total Employee:
101+
Status:
Active
Contact:
650-363-2400
Email Addresses:
[email protected]
Total Funding:
226.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Pulse Biosciences
Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Scitech Medical
Scitech is a manufacturer of medical devices committed to developing technology to treat cardiac and vascular diseases.
Soundbite Medical Solutions
Soundbite is a medical device company developing products in the field of vessel preparation for management and treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Post-IPO Equity - Avinger
Lucas Venture Group
Lucas Venture Group investment in Series E - Avinger
Lucas Venture Group
Lucas Venture Group investment in Debt Financing - Avinger
Lucas Venture Group
Lucas Venture Group investment in Series C - Avinger
Official Site Inspections
http://www.avinger.com Semrush global rank: 2.74 M Semrush visits lastest month: 5.94 K
- Host name: 244.110.148.146.bc.googleusercontent.com
- IP address: 146.148.110.244
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Avinger" on Search Engine
Home | Avinger
Next-Gen OCT-Guided CTO Crossing System Now FDA Cleared. Learn more about onboard image-guidance for safety and precisionSee details»
Avinger Announces Strategic Partnership and up to $15 Million โฆ
Mar 7, 2024 REDWOOD CITY, CA / ACCESSWIRE / March 6, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and โฆSee details»
Avinger Company Profile - Craft
2024-04-09. Revenue. $7.7 M. FY, 2023. Company Summary. Overview. Avinger is a medical device company that designs, manufactures, and sells image-guided and โฆSee details»
Avinger - Crunchbase Company Profile & Funding
Avinger, Inc., a medical device company, engages in developing catheter-based technologies for treating vascular diseases. It offers Wildcat, a catheter that helps โฆSee details»
Avinger, Inc. (AVGR) Company Profile & Facts - Yahoo Finance
Description. Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by โฆSee details»
Avinger Announces Strategic Partnership and up to $15 Million โฆ
07-Mar-2024. Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge. Initial $7.5 Million Strategic Investment. โฆSee details»
Investor Relations | Avinger
Vascular disease isnโt going away. Real people continue to fight the progression and complications that result from PAD. Weโve won many battles but the war goes on and we donโt take our responsibility to create โฆSee details»
Investor Relations | Avinger
Jul 27, 2023 H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) Avinger will host a group presentation and one-on-one investor meetings with โฆSee details»
Healthcare Professionals | Avinger
Events with Avinger. Visit Avinger at the following upcoming events to learn more on how Lumivascular is radically changing the way vascular disease is treated. Past events. Case Studies. Patient Stories. Clinical โฆSee details»
2024-03-06 | NDAQ:AVGR | Press Release | Avinger Inc
Mar 6, 2024 News Press Releases. Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge. AVGR | March 6, 2024. โฆSee details»
Avinger - Contacts, Employees, Board Members, Advisors & Alumni
Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.See details»
Earnings call: Avinger announces Q4 and FY 2023 results with โฆ
Mar 21, 2024 Avinger (NASDAQ: AVGR ), a medical device company specializing in innovative treatments for vascular diseases, reported its financial outcomes for the fourth โฆSee details»
Earnings call: Avinger announces Q4 and FY 2023 results with โฆ
Mar 21, 2024 Avinger (NASDAQ: AVGR ), a medical device company specializing in innovative treatments for vascular diseases, reported its financial outcomes for the fourth โฆSee details»
Avinger - Funding, Financials, Valuation & Investors - Crunchbase
Avinger has raised a total of. $316.1M. in funding over 16 rounds. Their latest funding was raised on Mar 6, 2024 from a Post-IPO Equity round. Avinger is registered under the โฆSee details»
Avinger Announces Strategic Partnership and up to $15
Mar 7, 2024 Accesswire. Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge. Provided by Accesswire. Mar 6, 2024 โฆSee details»
Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2021 Results
We've added a new role in the organization in 2021, which is a sales associate role, which will work -- who will work with an established territory sales manager to help to develop a โฆSee details»
AVGR Press Release: Avinger Announces Strategic Partnership โฆ
Mar 6, 2024 The strategic partnership provides up to $15 million of equity funding from Zylox-Tonbridge in two tranches, a licensing agreement providing access for Avinger's โฆSee details»
Avinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call Transcript
Mar 21, 2024 Avinger, Inc. (NASDAQ: AVGR) Q4 2023 Earnings Call Transcript March 20, 2024. Avinger, Inc. misses on earnings expectations. Reported EPS is $-3.93 EPS, โฆSee details»
Avinger Announces Strategic Partnership and up to $15
Mar 6, 2024 REDWOOD CITY, CA / ACCESSWIRE / March 6, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and โฆSee details»
Policies | Avinger
We receive and store any information you enter on Avinger or provide to us in any other way. The types of Personal Information collected includes all information you may enter โฆSee details»